Ville Leinonen Selected Research

Normal Pressure Hydrocephalus

2/2022	Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
3/2021	Elevated CSF LRG and Decreased Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
1/2021	A Novel Genetic Marker for the C9orf72 Repeat Expansion in the Finnish Population.
1/2021	Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
11/2020	Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.
2/2020	Corticospinal excitability in idiopathic normal pressure hydrocephalus: a transcranial magnetic stimulation study.
10/2019	CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
1/2019	[11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus.
1/2018	S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
12/2017	Why Does the Health-Related Quality of Life in Idiopathic Normal-Pressure Hydrocephalus Fail to Improve Despite the Favorable Clinical Outcome?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ville Leinonen Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 09/2008
21	Normal Pressure Hydrocephalus 02/2022 - 01/2011
5	Pain (Aches) 10/2022 - 01/2007
4	Neuroinflammatory Diseases 02/2022 - 01/2014
4	Low Back Pain (Lumbago) 01/2022 - 04/2003
3	Amyloid Plaque 01/2022 - 12/2012
3	Musculoskeletal Pain 01/2022 - 03/2021
3	Failed Back Surgery Syndrome 01/2021 - 01/2019
2	Dementia (Dementias) 01/2022 - 01/2013
2	Pathologic Constriction (Stenosis) 01/2021 - 10/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 10/2019
2	Infections 01/2019 - 10/2017
2	Atrophy 01/2019 - 12/2016
2	Genetic Risk Score 01/2017 - 01/2015
2	Cognitive Dysfunction 04/2014 - 01/2013
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2021
1	Chronic Pain 03/2021
1	Brain Concussion (Cerebral Concussion) 02/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 06/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Movement Disorders (Movement Disorder) 10/2019
1	Hematoma 01/2019
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Neoplasms (Cancer) 10/2017
1	Glioma (Gliomas) 10/2017
1	Hydrocephalus (Hydrocephaly) 05/2017
1	Memory Disorders (Memory Loss) 12/2016
1	Disease Progression 01/2015
1	Type 2 Diabetes Mellitus (MODY) 06/2014
1	Brain Diseases (Brain Disorder) 01/2013
1	Amyloidosis 12/2012
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2011
1	Intervertebral Disc Displacement (Herniated Disc) 04/2003
1	Spinal Stenosis (Stenosis, Spinal) 02/2003

Drug/Important Bio-Agent (IBA)

26	Amyloid (Amyloid Fibrils)IBA 02/2022 - 10/2010
15	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2011
4	Apolipoproteins E (ApoE)IBA 01/2019 - 11/2012
3	Pain-FreeIBA 01/2022 - 03/2021
3	tau Proteins (tau Protein)IBA 01/2022 - 10/2010
3	Peptides (Polypeptides)IBA 10/2018 - 09/2008
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2015 - 01/2014
3	flutemetamolIBA 04/2014 - 12/2012
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2021
2	Apolipoprotein E4IBA 01/2017 - 11/2012
2	ApolipoproteinsIBA 01/2017 - 11/2012
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2014
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2012 - 10/2008
1	UbiquitinIBA 11/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2021
1	Adenosine Triphosphate (ATP)IBA 11/2021
1	MicroRNAs (MicroRNA)IBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Opiate AlkaloidsIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 06/2020
1	Pharmaceutical PreparationsIBA 01/2018
1	CalciumIBA 01/2018
1	adenovirus receptorIBA 10/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Antiviral Agents (Antivirals)IBA 10/2017
1	Amyloidogenic ProteinsIBA 01/2017
1	Prealbumin (Transthyretin)IBA 01/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2015
1	Opioid Receptors (Opioid Receptor)IBA 01/2015
1	ElementsIBA 10/2014
1	Insulin-Like PeptidesIBA 06/2014
1	Liver X ReceptorsIBA 01/2013
1	Coloring Agents (Dyes)IBA 12/2012
1	SilverIBA 12/2012
1	AntibodiesIBA 01/2010
1	CarbonIBA 10/2008

Therapy/Procedure

4	Spinal Cord Stimulation 10/2022 - 01/2019
2	Therapeutics 01/2021 - 01/2020
2	Cerebrospinal Fluid Shunts 12/2017 - 01/2013
1	Ambulatory Care (Outpatient Care) 01/2022
1	Activities of Daily Living (ADL) 10/2021
1	Decompression 01/2021
1	Transcranial Magnetic Stimulation 02/2020
1	Electrodes (Electrode) 01/2019
1	Ventriculoperitoneal Shunt 05/2017
1	Musculoskeletal Manipulations (Manipulative Therapy) 03/2016
1	Bed Rest (Bedrest) 01/2015
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2007
1	Diskectomy (Discectomy) 04/2003
1	Denervation 02/2003